glp 1 and atrial fibrillation Impact of GLP-1 Receptor Agonist Therapy on Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis Glucagon-like peptide-1 receptor agonists and

Name: glp 1 and atrial fibrillation Impact of GLP-1 Receptor Agonist Therapy on Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis Glucagon-like peptide-1 receptor agonists and
Brand: buntepalette-gmbh.de
SKU: 56632463156
Price: 28.93 USD
Availability: InStock
Rating: 4.4302 (17 reviews)

SKU: 56632463156

4.4

DKK28.93 DKK72.93

Pay in 4 interest-free payments of $7.23 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Glucagon like peptide 1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real world study Journal of General Internal Medicine Springer Nature Link GLP1 Therapy Improves Atrial Fibrillation Outcomes After Catheter Ablation, Miller School Study Finds InventUM Abstract 4368472: Glucagon Like Peptide 1 Mediated Reduction in Atrial Fibrillation Risk Is Independent of Weight Loss Circulation The role of glucagon like peptide 1 receptor (GLP 1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF) Cardiovascular Diabetology Springer Nature Link

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de

Description

For the cardiovascular events in our study, we calculated the risk ratio (RR) with 95% confidence intervals (CIs) to standardize the differences between the GLP-1 receptor agonist and placebo